Artificial cells, cell engineering and therapy. (2007)

• Record Type: Book
• Further Information: Note: Edited by S. Prakash.
• Other Names: Prakash, S
• Contents: Cover; Artificial cells, cellengineering andtherapy; Copyright; Contents; Contributor contact details; Preface; Acknowledgements; Part I The artificial cell; 1 Introduction to artificial cells: concept, history, design, current status and future; 1.1 Introduction: concept and history; 1.2 Designing an artificial cell; 1.3 Microcapsule design membrane materials; 1.4 The diversity of artificial cell preparation methods; 1.5 Production of artificial cells:microencapsulation technologies; 1.6 Artificial cellmicrocapsule membrane characterization. 1.7 Artificial cells: current status and future prospective1.8 Conclusions and future trends; 1.9 Acknowledgements; 1.10 References; 2 Polymeric hydrophilic polymers in targeted drug delivery; 2.1 Introduction; 2.2 Properties and classification of hydrophilic polymers; 2.3 Targeting mechanisms and materials approaches; 2.4 Conclusions; 2.5 References; 3 The artificial cell design: liposomes; 3.1 Introduction; 3.2 Liposome structure and preparation; 3.3 Conventional liposome formulations; 3.4 Targeted drug delivery using liposomes; 3.5 Future trends. 3.6 Sources of further information and advice3.7 References; 4 The artificial cell design: nanoparticles; 4.1 Introduction; 4.2 In vivo properties of nanoparticles; 4.3 Design of polymeric nanoparticles; 4.4 Medical applications of nanoparticles; 4.5 Commercial development of nanoparticles; 4.6 Future trends; 4.7 Sources of further information and advice; 4.8 References; Part II Cell engineering; 5 The cutting edge: apoptosis and therapeutic opportunity; 5.1 Apoptosis; 5.2 Apoptosis and neurodegeneration; 5.3 Cell death during stroke; 5.4 Strokemanagement. 5.5 Neuronal cell death and Parkinson's disease5.6 Therapeutics; 5.7 Advances in development of neuro-protective agents; 5.8 Neuronal cell death and Alzheimer's disease; 5.9 Apoptosis and cancer; 5.10 Future trends; 5.11 Acknowledgements; 5.12 References and further reading; 6 Bone marrow stromal cells in myocardial regeneration and the role of cell signaling; 6.1 Introduction; 6.2 Cellular cardiomyoplasty and myocardial repair; 6.3 Mesenchymal stromal cells as adult stem cells; 6.4 Plasticity of adult MSC:milieu-dependent differentiation; 6.5 Cardiomyocytic differentiation of MSC. 6.6 Stem cell niche6.7 Cell signaling and mechanisms of differentiation; 6.8 Homing of the MSC to the infarcted site; 6.9 Therapeutic use of MSC; 6.10 Conclusions; 6.11 Future trends; 6.12 References; 7 Musculoskeletal tissue engineering with skeletal muscle-derived stem cells; 7.1 Introduction; 7.2 Identification of the optimal cell source; 7.3 Ability for cell expansion ex vivo; 7.4 Cell engineering for therapeutic applications; 7.5 Current progress with MDSCs; 7.6 Future trends; 7.7 Acknowledgements; 7.8 References; Part III Artificial cells for cell therapy.
• Publisher Details: Boca Raton, Florida Cambridge, England : CRC Press Woodhead Publishing Limited
• Publication Date: 2007
• Copyright Date: 2007
• Extent: 1 online resource (537 pages), illustrations
• Subjects: 610.28; Artificial cells; Artificial cells; Electronic books
• Languages: English
• ISBNs: 9781845693077; 1845693078
• Related ISBNs: 9781845690366
• Notes: Note: Includes bibliographical references at the end of each chapters and index.; Note: Print version record.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.